The bottleneck is never the platform.
Pharmaceutical social media management built around the constraint every other agency treats as an afterthought: every post, every reply and every image has to be approvable, which means the publishing cadence has to be designed around your review capacity from the start.
A social calendar built the way a consumer brand would build one — daily posts, rapid response, trend-jacking — collides immediately with medical review. The account either goes silent waiting for approval or starts publishing content nobody actually checked, and neither is acceptable.
A content calendar sized to your approval capacity, platform-appropriate content within approved claims, a comment and community management policy that flags what needs medical input, and reporting on what social can realistically achieve here.
Our community management policy is built to catch anything clinical in comments or DMs and route it straight to your team, rather than have anyone here attempt to answer it.
The scope our pharmaceutical social media management work has operated within.
The realistic objective differs by company type. Pharmaceutical social media management starts there.
What comes up when planning a regulated social presence.
Realistic cadence depends on your internal review capacity, since every post for a regulated brand needs sign-off before it goes live. We set a frequency your reviewers can sustain rather than promising a schedule that stalls after a month. Most regulated pharma accounts post less often than a typical consumer brand, and that lower cadence is the correct choice.
We respond within an agreed policy that we define with you before the channel launches. Anything clinical in nature, such as a question about a specific product or an adverse event report, is routed straight to your team rather than answered by us. That escalation boundary is set in writing before the channel goes live, not improvised afterward.
Product promotion depends on the platform and your product category, since most social platforms restrict or ban prescription drug advertising outright. We check what is permitted for your specific products before building any content plan around them, the same scoping step we apply to paid media. Over-the-counter products typically have more room than prescription-only ones.
LinkedIn is usually the priority for a pharmaceutical company, given its professional and investor-facing audience — see LinkedIn management for how we run that channel specifically. Other platforms only make sense once we have confirmed your audience is consumer-facing rather than clinical or corporate, which is not the case for most pharma brands.
Social media management pairs closely with LinkedIn and content marketing work. These are the related services.
An account that has gone quiet waiting for approvals, or one about to launch. Tell us your review process and we will tell you how we would approach the pharmaceutical social media management.